4 - 6 June, 2024
Excel London Platinum Suite Konrad Krawczyk, PhDCEO at NaturalAntibodySpeaker
Profile
Konrad Krawczyk has more than a decade experience in developing databases and computational models for therapeutic antibody discovery, contributing to Oxford University resources such as SAbDab/SAbPred platform and the Observed Antibody Space, that are used widely by academia and industry. He is the founder of NaturalAntibody that focuses on building computational/machine learning tools to accelerate therapeutic antibody discovery.
Agenda Sessions
Comprehensive Benchmarking of Computational/ML Discovery Protocols: The Benefits and Pitfalls for Biologics Discovery
, 16:15View Session